Received by email:

File: NR orion announces clarice thomas to adivsory board feb 2019 v4.docx

NEWS RELEASE

Orion Nutraceuticals Adds Clarice Thomas to Advisory Board

Vancouver, BC, February 21, 2019 - Orion Nutraceuticals Inc., (CSE: ORI) (the "Company" or "Orion") a cannabis life sc
--->ience company, is pleased to announce the addition of Clarice Thomas, to its advisory board.

As Co -Founder of I.O. Domani, a luxury retail boutique and other Co-Developing business ventures, located in Cabo San
---> Lucas, Mexico she prides herself with being a focused and fearless negotiator. Clarice currently resides between Dall
--->as, TX and Cabo San Lucas, Mexico. 
 
Clarice Thomas joined ATV Broadcast as Vice President of New Media in 2012, after 20 years of marketing and sales proj
--->ect management. In 2014 Clarice and three business colleagues formed Belfor Media a sister company to ATV Broadcast sy
--->ndicating internationally distribution and digital media globally, with offices in Dallas, London, New York and Indian
--->apolis. Clarice has experience in both the public and private sectors including Director of Marketing for DBC America 
--->based in Helsinki, Finland. Clarice also served as Chief Administration Officer at Pinnacle Excavation specializing in
---> underground utilities. Clarice Thomas Inc was founded in 2006 she served as the Relationship Consultant, acting as th
--->e liaison between the developers and retailers, interacted with resources in the private equity and hedge fund space f
--->or identifying viable investors. 

Clarice's expertise includes: Building functional collaborative teams and is recognized for her leadership abilities d
--->riving and responding to market trends, producing top sales practices, methodologies, relationship building skills, pr
--->oject management and branding identity. Clarice has set a presence in C.S.L., Mexico as being a minority woman & partn
--->er in a Mexican based construction company, interior design, manufacturing, logistics and vendor sourcing.

In 2015 Clarice joined EAST CAPE 65, LLC to oversee Business Development for the real estate resort hotel project in S
--->an Jose Del Cabo, Mexico. Handpicked as key member of management team to assist with launch of $200MM+ resort hotel/re
--->al estate/spa/restaurant in Mexico from initial funding to pre-construction project. Clarice will wear multiple hats t
--->o assist overseeing: strategic planning/execution, feasibility studies reporting, local municipal relationships/entitl
--->ement, identifying multi-phased funding, sales, client/partner relationships, contract negotiations/operations, projec
--->t management, to local vendor sourcing; along with working hand in hand with Dallas Based Developer Gate House Capital
---> and Nunzio Marc DeSantis Architects also of Dallas, TX.


"We are excited to announce Clarice Thomas will be joining Orion Nutraceutical's advisory board", said Jonathan Fiteni
--->, CEO of Orion. "Her business experience and connections will prove to be invaluable in developing new products, conne
--->cting Orion with sports professionals and furthering our stated goal of becoming a global presence in the world of spo
--->rts medicine".

The Company also wishes to announce that it has granted incentive stock options of the Company to Clarice Thomas for t
--->he right to purchase up to an aggregate of 300,000 common shares of the Company, exercisable at the price of $0.215 pe
--->r share for two years. The effective date of the grant of option is January 15, 2019. The options will vest in 2 tranc
--->hes of 150,000 options each, with the first 150,000 options issued following the Company's announcement and the additi
--->onal 150,000 options 6 months after. The stock options granted will be in accordance with the Company's Stock Option P
--->lan and will have the required four months hold period legend, pursuant to the Policies of the CSE and regulatory auth
--->orities.

About Orion Nutraceuticals Inc.
Orion Nutraceuticals Inc. aims to set a new standard in cannabis life science by producing and developing innovative p
--->roducts with key strategic partners in the industry. In conjunction with its professional sports strategic alliances, 
--->the company is poised to advance research and development in the plant science sector, deliver science-based products 
--->and services, and market CBD therapies to the mainstream with proprietary brands and products. Medic-Oasis, Orion's su
--->bsidiary, has submitted its application for an ACMPR license and is currently under review with Health Canada. Build o
--->ut is expected to begin in Q1 2019, with completion of the 30,000 square foot facility expected by Q3 2019. Orion Nutr
--->aceuticals is partners with Colombian based medical cannabis corporation FCM Global. FCM supplies pharmaceutical, nutr
--->itional, wellness, and cosmetic companies in legal markets worldwide with customized medical cannabis extracts, oils, 
--->and isolates at commercial scale. Orion shares trade in Canada on the CSE under the symbol ORI.

ON BEHALF OF THE BOARD

Jonathan Fiteni, CEO 
Orion Nutraceuticals Inc.
www.orionnutra.ca

Investor Relations
Robin Linden, Director
1.604.313.2768
investors@orionnutra.ca

Keep up to date with Orion on our social media channels:

Twitter: @orionnutra
Facebook: @orionnutra
Instagram: @orionnutra
LinkedIn: @orionnutra

This news release may contain forward-looking statements based on assumptions and judgments of management regarding fu
--->ture events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual e
--->vents or results to differ materially from those reflected in the forward-looking statements. The company disclaims an
--->y intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing
---> the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis 
--->and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities descri
--->bed herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or 
--->CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsi
--->bility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities desc
--->ribed herein in the United States. The securities described herein have not been registered under the United States Se
--->curities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or so
--->ld in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless r
--->egistered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration re
--->quirements is available.